Tampa, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) — RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to patients with obstructive sleep apnea, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and visibility with current and potential shareholders while refining and expanding our overall message and reach. This is in anticipation and due to the overwhelming response from the public and medical field following the approval and release to market of our pending DeltaWave 510k.
“We believe we owe it to our current and future investors for partnering with a flagship company to help drive our investor relations forward. Maintaining an open line of communication with our shareholders and providing consistent and timely updates will only serve to add value to our business,” said Tom Wood, CEO of RemSleep.
Ms. Preya Narain, Founder of Preya Co is an experienced microcap consultant based in New York. Her background as a very active day-trader has led her to seek to serve businesses and investors with greater purpose, impact, positivity and perspective. In 2020, she assembled a team of high performing professionals and formed Preya Co., a team of consultants with over twenty years of combined experience in the OTC, OTCQB/QX, foreign and NASDAQ markets. Preya Co. is currently a corporate advisor, investor relations manager and social media manager for several publicly traded companies in the space, as well as extensive forensic research and due diligence reporting for issuers, shareholders, regulators and federal organizations.
MCAP Mediawire is a leading competitor in the news distribution space, providing the number one press release, digital media and financial disclosure services for microcaps and publicly traded companies. Their services provide businesses with exposure to an audience of millions, including journalists, investors, day-traders, fund managers, and social media/messaging platforms. This allows press releases, tax returns, branded articles, shareholder updates and company achievements to reach a wide and diverse audience across the globe.
We encourage our shareholders to visit our official Twitter account for RemSleep Holdings Inc at https://twitter.com/RemsleepInc.
About RemSleep Holdings Inc.
RemSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to patients with obstructive sleep apnea. Our focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the REMSleep team has a deep knowledge and understanding of CPAP and patient compliance challenges. We strive diligently to ensure that our products make a difference and improve the condition of people suffering from sleep apnea.
Certain statements contained in this press release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without (limited to, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by the use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “have the ‘intent’, ‘plan’ or ‘project’ or the negative of these words or other variations of these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, which may cause the Company’s actual results to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially current expectations include, among others, the Company’s inability to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, as well as e other risks disclosed in the Company’s public disclosure filing with the relevant securities regulatory authorities. Nothing contained in this press release should be construed as any indication of future revenues, results of operations or the Company’s share price. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in the forward-looking statements, there may be other factors that cause actual results or events not to be not those anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this press release are made as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise, unless the applicable securities so require. legislation.